IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MORLACCHI, LETIZIA CORINNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.878
NA - Nord America 7.668
AS - Asia 7.199
SA - Sud America 608
AF - Africa 180
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.587
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.418
IT - Italia 3.138
SG - Singapore 2.162
CN - Cina 2.059
GB - Regno Unito 1.481
DE - Germania 997
HK - Hong Kong 709
BD - Bangladesh 654
VN - Vietnam 539
RU - Federazione Russa 521
BR - Brasile 446
SE - Svezia 438
FR - Francia 346
IN - India 332
NL - Olanda 251
ID - Indonesia 193
IE - Irlanda 174
CA - Canada 166
KR - Corea 126
FI - Finlandia 104
CI - Costa d'Avorio 94
JP - Giappone 81
ES - Italia 74
DK - Danimarca 73
TR - Turchia 68
AR - Argentina 58
AT - Austria 50
AU - Australia 47
PH - Filippine 43
MX - Messico 37
UA - Ucraina 37
PL - Polonia 36
IQ - Iraq 33
CH - Svizzera 32
ZA - Sudafrica 28
BE - Belgio 26
VE - Venezuela 25
PK - Pakistan 23
EC - Ecuador 20
AE - Emirati Arabi Uniti 19
CL - Cile 18
MY - Malesia 17
IR - Iran 15
EG - Egitto 14
AL - Albania 13
IL - Israele 13
NP - Nepal 13
SA - Arabia Saudita 13
TH - Thailandia 13
TW - Taiwan 12
UZ - Uzbekistan 12
CZ - Repubblica Ceca 10
PY - Paraguay 10
TN - Tunisia 10
LU - Lussemburgo 9
PT - Portogallo 9
RO - Romania 9
CO - Colombia 8
GR - Grecia 8
JO - Giordania 8
PE - Perù 8
UY - Uruguay 8
BG - Bulgaria 7
CR - Costa Rica 7
LT - Lituania 7
AZ - Azerbaigian 6
DZ - Algeria 6
HN - Honduras 6
LB - Libano 6
NO - Norvegia 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
KE - Kenya 5
BN - Brunei Darussalam 4
BO - Bolivia 4
ET - Etiopia 4
EU - Europa 4
GE - Georgia 4
MA - Marocco 4
PA - Panama 4
PR - Porto Rico 4
BB - Barbados 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
BH - Bahrain 2
BS - Bahamas 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RS - Serbia 2
Totale 23.561
Salva come PNG Salva come JPEG
Città #
Southend 1.268
Singapore 1.217
Ashburn 958
Frankfurt am Main 669
Milan 650
Hong Kong 627
Dallas 471
Chandler 454
San Jose 447
Council Bluffs 332
Santa Clara 307
Beijing 293
Los Angeles 281
Hefei 269
Fairfield 266
Ann Arbor 231
Rome 228
Wilmington 188
Princeton 185
New York 184
Dublin 170
Buffalo 166
Chicago 162
Ho Chi Minh City 162
Jakarta 147
Lauterbourg 135
Bengaluru 134
Hanoi 132
Seattle 132
Woodbridge 123
Guangzhou 122
Houston 113
Cambridge 105
Seoul 105
Boardman 103
Abidjan 94
Toronto 94
Moscow 87
Des Moines 72
Salt Lake City 71
Nanjing 70
Dearborn 69
Naples 69
Bologna 68
Munich 68
The Dalles 57
Turin 57
Phoenix 56
Tokyo 56
Florence 54
Shanghai 53
Helsinki 50
Cangzhou 48
Columbus 42
Genoa 37
Medford 37
Palermo 37
São Paulo 36
Changsha 34
Nuremberg 33
Shenzhen 32
Da Nang 31
Redwood City 30
Tampa 30
Atlanta 29
Tianjin 29
Vienna 29
Istanbul 28
San Diego 28
Berlin 27
Bari 26
Verona 26
Basingstoke 25
Elk Grove Village 25
Catania 24
Hanover 24
London 24
Montreal 24
Brooklyn 23
Haiphong 23
Washington 23
Barcelona 22
Fuzhou 22
Monza 22
Shenyang 22
Zhengzhou 22
Central District 21
Orem 21
Paris 21
Amsterdam 20
Dong Ket 20
Sydney 20
Turku 20
Brussels 19
Jinan 19
Trieste 19
Boston 18
Hebei 18
Madrid 18
Wuhan 18
Totale 13.927
Salva come PNG Salva come JPEG
Nome #
Trapianto polmonare: oto score e sopravvivenza a medio termine 934
L’immunoadsorbimento come trattamento del rigetto umorale dopo trapianto polmonare 486
Come scrivere un articolo scientifico = How to write a scientific paper 478
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 373
Trapianto di polmone da donatore marginale a cuore non battente non controllato su ricevente critico : un caso complesso 356
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 309
Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis : serum inflammatory biomarkers, clinical efficacy,and microbiological eradication 278
Early Pulmonary Function and Mid Term Outcome in Lung Transplantation after Ex Vivo Lung Perfusion- a single-center, retrospective, observational, cohort study 271
Nocardia infections after lung transplantation: a case series 268
Sette anni di EVLP presso la Fondazione IRCCS Ca’ Granda di Milano 260
Lung Transplantation From Controlled and Uncontrolled Donation After Circulatory Death (DCD) Donors With Long Ischemic Times Managed by Simple Normothermic Ventilation and Ex-Vivo Lung Perfusion Assessment 259
Five years of EVLP: a monocentric experience 258
Bronchoalveolar Lavage-microRNAs Are Potential Novel Biomarkers of Outcome after Lung Transplantation 258
Lung transplantation from donors after previous cardiac surgery: ideal graft in marginal donor? 253
Hemodynamic failure and graft dysfunction after lung transplant: A possible clinical continuum with immediate and long-term consequences 245
Pathogenetic lung-infiltrating TH1/17 cells as new target in cystic fibrosis lung transplantation recipients : preliminary results 245
Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) 244
Extended-criteria uncontrolled DCD donor for a fragile recipient: A case report about a challenging yet successful lung transplantation 231
A single center experience of ex-vivo lung perfusion program: early and long term post-transplant outcome 228
Clamshell vs bilateral anterolateral thoracotomy for double lung transplantation : impact on vital capacity 225
Feasibility of surveillance after lung transplantation using multivolume MRI instead of ionizing radioation techiques in cystic fibrosis patients 225
COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy 219
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 215
Cytomegalovirus prophylaxis after lung transplantation: a single centre experience 205
CMV: reactivation and prematurely discontinued prophylaxis 205
Lung Biomolecular Profile and Function of Grafts from Donors after Cardiocirculatory Death with Prolonged Donor Warm Ischemia Time 203
Challenges in the Diagnosis and Management of Bacterial Lung Infections in Solid Organ Recipients: A Narrative Review 201
Anti-HLA Antibodies before and after Lung Transplantation: A Role on Medium-Long Term Outcomes? 200
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020 200
Bone Disease in Long-Term Lung Transplant Survivors 197
Impact of Cold Ischemic Time on Airway Complications After Lung Transplantation: A Single-center Cohort Study 194
The role of pulmonary arterial wedge pressure in primary graft dysfunction 192
Hesitancy toward the Full COVID-19 Vaccination among Kidney, Liver and Lung Transplant Recipients in Italy 189
Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure 189
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 188
Multivolume proton-magnetic resonance imaging (1H-MRI) in lung transplant recipients: comparison with low dose computed tomography (CT) 188
Spns2 Transporter Contributes to the Accumulation of S1P in Cystic Fibrosis Human Bronchial Epithelial Cells 186
Complicanze bronchiali dopo trapianto di polmone: analisi dei fattori di rischio 185
Immune checkpoints expression in chronic lung allograft rejection 184
Ex-vivo lung perfusion: 5 anni di esperienza monocentrica 183
Regional analysis with quantitative computed tomography after lung transplantation 179
Usefulness of autofluorescence bronchoscopy in early diagnosis of airway complications after lung transplantation 179
Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial 175
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 174
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 173
Conversion to extend release tacrolimus in early post-lung transplantation period 173
Immunopathology of lung transplantation: from infection to rejection and vice versa 172
Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm 172
Lung Allocation Score : a Single-Center Simulation 172
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients 172
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 171
Insights Into the Lung Microenvironment During Chronic Allograft Rejection: The Role of Bal-Evs in Rewiring Respiratory Cells Inflammatory Response 169
A Real-Life Evaluation of Criteria for Listing for Lung Transplant: A Single-Center, Five-Year Experience 169
Quality of Life and Lung Function in Survivors of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome 168
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine 165
Lung Transplantation after Covid-9 : first italian experience 165
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 164
Use of Dupilumab in Asthma Relapse After Lung Transplant 162
Conversion to extended release tacrolimus in early post lung transplantation period : a pilot study 162
Sympatho-Vagal Dysfunction in Patients with End-Stage Lung Disease Awaiting Lung Transplantation 162
Early acute rejection after lung transplantation mimicking viral pneumonia in the middle of COVID-19 pandemic : a case report 157
Lipidome profile of Cystic Fibrosis Related Diabetes, Type 1 and Type 2 Diabetes Mellitus: potential links to inflammation and glucose and lipid metabolism 157
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study 156
Intraoperative extra-corporeal membrane oxygenation during lung transplantation. Predicive factors and mid-term outcome in a single center 155
Longitudinal assessment of renal function after lung transplantation for cystic fibrosis: transition from post-operative acute kidney injury to acute kidney disease and chronic kidney failure 154
Diagnostic Yield of Transbronchial Cryobiopsies for the Diagnosis of Rejection in Lung Transplant Patients 154
Lobar Lung Transplantation From Deceased Donor: Monocentric Experience 153
Infections after lung transplantation 153
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 151
Diaphragm and Lung Transplantation 150
EVLP: a monocentric five years experience 150
Immune Checkpoint Espression Associates with Rejection in Lung Transplant Recipients 150
Lung Donor Bronchoalveolar Lavage Positivity: Incidence, Risk Factors, and Lung Transplant Recipients' Outcome 148
Effects of bilateral lung transplantation on cardiac autonomic modulation and cardiorespiratory coupling : a prospective study 148
Clamshell versus bilateral anterolateral thoracotomy for double lung transplantation: impact on functional and clinical outcomes 147
Lobectomia su banco del graft per trapianto di polmone: esperienza monocentrica 147
The pro-inflammatory role of EVs in chronic lung rejection 146
OTO Score and medium-term survival in lung transplantation 146
Kaposi's Sarcoma in Lung Transplantation: A Decade's Single-Centre Case Series 146
Analisi quantitativa polmonare mediante tomografia computerizzata nel primo anno dopo trapianto di polmone 145
Lung transplantation after ex vivo lung perfusion: a monocentric midterm follow-up 144
BAL-EVs from LungTransplanted Patients are of LeukocyticOrigin and Activates IL17 Pathway inRespiratory Cells 143
Lung Transplantation and Extracorporeal Photopheresis as Induction Therapy in Cystic Fibrosis Patients: Immune System Profile Changes 143
Valutazione del profile anticorpale al momento del trapianto di polmone e suo impatto sull’outcome a medio termine in termini di sopravvivenza, rigetto cellular e clad (chronic lung allograft disfunction) 142
Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis 138
Interventional pulmonology techniques in lung transplantation 137
New insights in non-invasive markers for rejection in lung transplanted patients 137
PD-1 expression in transbronchial biopsies of lung transplant recipients is a possible early predictor of rejection 136
Lung Transplantation for Acute Respiratory Distress Syndrome Related to COVID-19: The Lesson Learned from the First Two Cases 136
Ten Years of ECP for CLAD: A Real Life Experience 135
Diagnostic delay in bronchiectasis: an Italian perspective 134
Trapianto di polmone e disordini linfoproliferativi post trapianto (PTLD) ebv-correlati 134
The effect of primary graft dysfunction after lung transplantation on parenchymal remodeling detected by quantitative computed tomography 134
Conversione precoce a tacrolimus a rilascio prolungato dopo trapianto di polmone 133
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 132
Chronic lung allograft dysfunction after lung transplantation: prevention, diagnosis and treatment in 44 European centres 131
Altered Lipid Metabolism in the Follow Up of Cystic Fibrosis Lung Transplant Patients 128
Bilateral lung transplantation in severe chest asymmetry: case series from a single center 127
Oto score and medium-term outcomes in lung transplantation 127
Ten years experience of uncontrolled dcd program on a medium-volume lung transplantation centre 126
Totale 19.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20221.525 91 65 64 105 188 102 83 90 191 115 92 339
2022/20231.795 172 181 169 148 178 312 59 133 201 39 130 73
2023/20242.130 72 100 90 117 412 114 176 171 109 186 267 316
2024/20254.836 200 441 160 435 369 252 159 391 238 439 906 846
2025/202610.399 872 799 1.125 852 774 584 1.265 456 974 690 1.095 913
Totale 24.504